Toxsta® – Botulinum Toxin Type A [South Korea]

Toxsta – Botulinum Toxin Type A | Research-Grade Toxin from South Korea

Product Overview

Toxsta is a research-grade Botulinum Toxin Type A developed and manufactured in South Korea, designed specifically for laboratories and institutions engaged in neuromuscular and aesthetic science research. Known for its consistent biological activity and competitive purity, Toxsta is a reliable and cost-effective option for experimental modeling in the fields of muscle relaxation, neurotransmission inhibition, and anti-aging mechanisms.

While Toxsta is not as internationally recognized as brands like Nabota® or Botulax®, it has gained steady traction in the research market for its performance and affordability. This product is intended strictly for Research Use Only (RUO) and is not approved for clinical, therapeutic, or cosmetic use in humans or animals.

---

Key Features & Advantages

• ✅ Manufactured in South Korea
  Produced in GMP-compliant facilities with standardized quality control protocols.

• ✅ Effective Potency for Research Models
  Demonstrates stable onset and predictable diffusion in laboratory conditions.

• ✅ Purified Formulation
  Contains low levels of bacterial proteins to reduce risk of experimental variability.

• ✅ Competitive Pricing for Laboratories
  A budget-friendly alternative to premium Botulinum toxin products without compromising performance in RUO applications.

• ✅ Consistent Performance in Repeated Testing
  Suitable for studies requiring reproducibility, especially in neuromuscular signal interruption and localized muscle inhibition.

---

Product Specifications

• Product Name: Toxsta – Botulinum Toxin Type A

• Active Ingredient: Clostridium botulinum toxin type A

• Form: Lyophilized powder

• Packaging: 100 Units / vial

• Appearance: White to off-white freeze-dried powder; forms clear solution upon reconstitution

• Origin: South Korea

• Storage Conditions: 2°C–8°C refrigerated; reconstituted solution should be used within 24 hours

• Use Classification: Research Use Only (RUO) – not for diagnostic, therapeutic, or cosmetic use

---

How It Works – Mechanism of Action

Toxsta functions by inhibiting acetylcholine release at neuromuscular junctions, thereby inducing temporary muscle paralysis in targeted regions. Once administered, the toxin binds selectively to presynaptic cholinergic nerve endings and is internalized. Inside the neuron, it cleaves SNAP-25, a key SNARE protein that facilitates acetylcholine vesicle docking and release.

By disrupting this process, Toxsta silences the neuromuscular signal transmission pathway, making it a valuable tool in the study of facial muscle dynamics, hyperactive muscle response, chronic pain mechanisms, and cosmetic toxin modeling. Its biological mechanism mirrors that of other Botulinum Toxin Type A products used globally in clinical settings, allowing for comparative experimental research.

For academic literature on Botulinum Toxin Type A’s pharmacology, refer to PubMed resources.

---

Applications in Research

• Facial muscle paralysis and dynamic wrinkle modeling

• Neuromuscular transmission inhibition

• Anti-aging and skin relaxation compound screening

• Hyperhidrosis and spasticity modeling in vitro

• Toxin comparison studies involving SNAP-25 cleavage efficiency

---

Compliance Statement

This product is manufactured in South Korea and is officially exported for non-clinical research use only. Toxsta is not approved for human or veterinary injection, diagnosis, or therapeutic application. All users are responsible for ensuring compliance with local regulations regarding the storage, handling, and usage of biologically active toxins.

---

Tags / Keywords

Toxsta, Korean Botulinum Toxin, Botulinum Toxin Type A, RUO Botulinum, Research Use Only Toxin, Muscle Inhibition Studies, SNAP-25 Cleavage Research, Neurotransmitter Blocking Agent, Aesthetic Research Botulinum, Toxin for Laboratory Testing

---

External References

• Basic Research on Botulinum Toxin A – PubMed

• WHO: Botulinum Toxin Fact Sheet

• Overview of Botulinum Products – NIH